Genetic interactions between the coagulation and fibrinolytic systems

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 130-137

  Degen, J L ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Coagulation; Fibrinolytics; Gene targeting; Platelets

Indexed keywords

ANTITHROMBIN III; BETA3 INTEGRIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; ENDOTHELIAL CELL GROWTH FACTOR; FIBRINOGEN; FIBRINOLYTIC FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PADGEM PROTEIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTHROMBIN; THROMBOCYTE FACTOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN; VON WILLEBRAND FACTOR;

BLEEDING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; CONFERENCE PAPER; DISEASE MODEL; EXPERIMENTAL ANIMAL; FIBRINOGEN DEFECT; FIBRINOLYSIS; GENE TARGETING; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; GENETIC MANIPULATION; HEMOSTASIS; IN VIVO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSGENIC MOUSE;

EID: 0034912166     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616209     Document Type: Conference Paper

References (100)

1. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation
2. Targeted disruption of the murine tissue factor gene results in embryonic lethality
3. Effect of tissue factor deficiency on mouse and tumor development
4. Role of tissue factor in embryonic blood vessel development
5. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding
6. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice
7. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
8. A factor IX-deficient mouse model for hemophilia B gene therapy
9. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies
10. A murine model of factor XI deficiency
11. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V
12. Prothrombin deficiency results in embryonic and neonatal lethality in mice
13. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice
14. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
15. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3
16. A coagulation factor IX-deficient mouse model for human hemophilia B
17. Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice
18. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
19. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system
20. Intravascular coagulation activation in a murine model of thrombomodulin deficiency: Effects of lesion size, age, and hypoxia on fibrin deposition
21. Inactivation of the gene for anticoagulant protein C cause lethal perinatal consumptive coagulopathy in mice
22. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice
23. Consequences of tissue factor pathway inhibitor gene-disruption in mice
24. Complete antithrombin deficiency in mice results in embryonic lethality
25. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
26. Role of the thrombin receptor in development and evidence for a second receptor
27. Sol Sherry lecture in thrombosis: How thrombin "talks" to cells: Molecular mechanisms and roles in vivo
28. A dual thrombin receptor system for platelet activation
29. Defective platelet activation in G alpha(q)-deficient mice
30. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
31. Defects in hemostasis in P-selectin-deficient mice
32. Generation and rescue of a murine model of platelet dysfunction: The Bernard-Soulier syndrome
33. Syk tyrosine kinase required for mouse viability and B-cell development
34. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
35. The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils
36. Hematopoietic reconstitution of SLP-76 corrects hemostasis and platelet signaling through alpha IIbbeta 3 and collagen receptors
37. The molecular adapter SLP-76 relays signals from platelet integrin αIIbβ3 to the actin cytoskeleton
38. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76
39. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice
40. Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: Demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment
41. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state
42. Spontaneous thrombosis in mice carrying the factor V leiden mutation
43. Prothrombotic phenotype of protein Z deficiency
44. Physiological consequences of loss of plasminogen activator gene function in mice
45. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis
46. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
47. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
48. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice
49. Generation and characterization of urokinase receptor-deficient mice
50. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding
51. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
52. The murine urokinase-type plasminogen activator receptor gene
53. Assembly and secretion of recombinant human fibrinogen
54. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen
55. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
56. The plasminogen (fibrinolytic) system
57. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice
58. Impaired wound healing in mice with a disrupted plasminogen gene
59. Ligneous conjunctivitis in plasminogen-deficient mice
60. Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice
61. Lactational competence and involution of the mouse mammary gland require plasminogen
62. Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice
63. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury
64. Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver
65. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction
66. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin
67. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus
68. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice
69. The generation of enzymatically active plasmin on the surface of spirochetes
70. The plasminogen activation system enhances brain and heart invasion in murie relapsing fever borreliosis
71. Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice
72. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
73. Plasminogen is a critical determinant of vascular remodeling in mice
74. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
75. Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes
76. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice
77. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
78. Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets
79. Exposure of binding sites for vitronectin on platelets following stimulation
80. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins
81. Mechanisms initiating platelet thrombus formation
82. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen and GPIIbIIIa receptor
83. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood
84. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions
85. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
86. Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit
87. Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice
88. The characterization of mice with a targeted combined deficiency of protein C and factor XI
89. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression
90. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice
91. Mice lacking the thrombin receptor, PAR1, have normal skin wound healing
92. Thrombin signalling and protease-activated receptors
93. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin
94. PAR3 is a cofactor for PAR4 activation by thrombin
95. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
96. Vitronectin is not essential for normal mammalian development and fertility
97. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
98. Vitronectin inhibits the thrombotic response to arterial injury in mice
99. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice
100. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization